Top

Published in:

01-05-1998 | Original Research Article

Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients

Authors: Dr George Dranitsaris, Peter Phillips, Coleman Rotstein, Anitasha Puodziunas, Steve Shafran, Gary Garber, Fiona Smaill, Irving Salit, Mark Miller, Kurt Williams, John Conly, Joel Singer, Steve Ioannou

Published in: PharmacoEconomics | Issue 5/1998

Title: Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients
Authors: Dr George Dranitsaris
Peter Phillips
Coleman Rotstein
Anitasha Puodziunas
Steve Shafran
Gary Garber
Fiona Smaill
Irving Salit
Mark Miller
Kurt Williams
John Conly
Joel Singer
Steve Ioannou
Publication date: 01-05-1998
Publisher: Springer International Publishing
Published in: PharmacoEconomics / Issue 5/1998
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI: https://doi.org/10.2165/00019053-199813050-00004

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/1998

Cost Effectiveness of Early Treatment with Oral Aciclovir in Adult Chickenpox

How to Calculate Indirect Costs in Economic Evaluations

Predicting Hospitalisation of Patients with Diabetes Mellitus

Assessing the Willingness of Parents to Pay for Reducing Postoperative Emesis in Children

The Economic Cost of Multiple Sclerosis in Sweden in 1994

The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data